enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Cannabinoid - Wikipedia

   en.wikipedia.org/wiki/Cannabinoid

   Tetrahydrocannabinol (THC) is the primary psychoactive component of the Cannabis plant. Delta-9-tetrahydrocannabinol (Δ 9-THC, THC) and delta-8-tetrahydrocannabinol (Δ 8-THC), through intracellular CB 1 activation, induce anandamide and 2-arachidonoylglycerol synthesis produced naturally in the body and brain [citation needed] [dubious ...

3. 5-MeO-DMT - Wikipedia

   en.wikipedia.org/wiki/5-MeO-DMT

   5-MeO-DMT was first synthesized in 1936 by Toshio Hoshino [9] , professor of Tokyo Institute of Technology, and was first isolated from a natural source in 1959. [5] It is a controlled substance in some countries, for instance the United States , United Kingdom , Australia , and New Zealand . [ 5 ]

4. Δ-8-Tetrahydrocannabinol - Wikipedia

   en.wikipedia.org/wiki/Δ-8-Tetrahydrocannabinol

   Δ-8-tetrahydrocannabinol (delta-8-THC, [a] Δ 8-THC) is a psychoactive cannabinoid found in the cannabis plant. [1] It is an isomer of delta-9-tetrahydrocannabinol (delta-9-THC, Δ 9-THC), the compound commonly known as THC, with which it co-occurs in hemp; natural quantities of ∆ 8-THC found in hemp are low.

5. Cannabidiol - Wikipedia

   en.wikipedia.org/wiki/Cannabidiol

   They would be made available to over 18s only, with the maximum daily dose of 60 mg/day, up to 2% THC finished product allowed, 30-day maximum supply, plant-derived or synthetic. This proposal is based on an initial literature review on the safety of low dose CBD published by the TGA in April 2020. [ 113 ]

6. Heavy marijuana use may fuel anxiety disorders, new ... - AOL

   www.aol.com/finance/heavy-marijuana-may-fuel...

   A 2020 study published in the Journal of Translational Medicine noted that THC—the main psychoactive ingredient in cannabis—has been noted to increase anxiety, while CBD—a cannabis ...

7. N,N-Dimethyltryptamine - Wikipedia

   en.wikipedia.org/wiki/N,N-Dimethyltryptamine

   In this study participants received the DMT dosage via intravenous injection and the findings suggested that different psychedelic experiences can occur, depending on the level of dosage. Lower doses (0.01 and 0.05 mg/kg) produced some aesthetic and emotional responses, but not hallucinogenic experiences (e.g., 0.05 mg/kg had mild mood ...